COMPARISON OF EFFICACY OF MODIFIED MASOOD SCORING INDEX IN CYTOLOGICAL DIAGNOSIS OF BREAST LESIONS WITH ITS HISTOPATHOLOGY
International Journal of Drug Delivery Technology · 17.06.2026 · 16 (54s)
DOI: 10.25258/ijddt.16.54s.14 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 17.06.2026. Verfasst von Nehil Srivastava und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Palpable breast lumps represent a frequent clinical concern requiring accurate diagnostic evaluation. Fine Needle Aspiration Cytology (FNAC) serves as a rapid, minimally invasive, and cost-effective diagnostic modality for the assessment of breast lesions. The Modified Masood Scoring Index (MMSI) further enhances cytological evaluation by categorizing lesions into non-proliferative breast disease, proliferative breast disease without atypia, proliferative breast disease with atypia, and carcinoma. Aim and Objectives To classify breast lesions using the Modified Masood Scoring Index, correlate cytological findings with histopathological diagnosis, and assess the applicability, diagnostic efficacy, reliability, reproducibility, and sensitivity of MMSI in breast lesion evaluation. Materials and Methods This observational study was conducted on 200 female patients aged 12–90 years presenting with palpable breast lumps measuring more than 1 cm. All patients underwent FNAC followed by histopathological examination. Cytological smears were evaluated using the MMSI scoring system (maximum score: 24), and the results were correlated with corresponding histopathological findings.
Results
The majority of patients belonged to the 30–39 years age group (37%), followed by the 20–29 years group (33.5%). Breast lump was the most common presenting complaint (84%). Based on MMSI scoring, 64% of cases were categorized as non-proliferative breast disease, 5.5% as proliferative breast disease without atypia, 1.5% as proliferative breast disease with atypia, and 29% as carcinoma. Histopathological examination revealed 60% benign and 29.5% malignant lesions. A high histo-cytological concordance rate of 86.5% was observed, which was statistically significant (p < 0.0001).
Conclusion
The Modified Masood Scoring Index is a reliable, reproducible, and effective cytological scoring system for the evaluation of breast lesions. It demonstrates excellent concordance with histopathological diagnosis and provides accurate differentiation between benign and malignant breast lesions, thereby facilitating standardized cytological reporting and improved diagnostic precision.
Zitieren
APA
Srivastava, N., Singh, J., & Khanna, S. P. (2026). COMPARISON OF EFFICACY OF MODIFIED MASOOD SCORING INDEX IN CYTOLOGICAL DIAGNOSIS OF BREAST LESIONS WITH ITS HISTOPATHOLOGY. International Journal of Drug Delivery Technology, 16(54s). https://doi.org/10.25258/ijddt.16.54s.14
Vancouver
Srivastava N, Singh J, Khanna SP. COMPARISON OF EFFICACY OF MODIFIED MASOOD SCORING INDEX IN CYTOLOGICAL DIAGNOSIS OF BREAST LESIONS WITH ITS HISTOPATHOLOGY. International Journal of Drug Delivery Technology. 2026;16(54s). doi:10.25258/ijddt.16.54s.14
BibTeX
@article{Srivastava2026,
author = {Srivastava, Nehil and Singh, Jaskirat and Khanna, Shiv Pankaj},
title = {COMPARISON OF EFFICACY OF MODIFIED MASOOD SCORING INDEX IN CYTOLOGICAL DIAGNOSIS OF BREAST LESIONS WITH ITS HISTOPATHOLOGY},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {54s},
doi = {10.25258/ijddt.16.54s.14}
}
EUVIMED